1[1]Parker S L. Cancer statistics-1996[J].CA Cancer J Clin, 1996,65:5.
2[2]Barinaga M.Study suggests new way to gauge prostate cancer risk[J].Science, 1998;279:475.
3[3]Jones J I, Clemmons D R.Insulin-like growth factors and their binding proteins: biological action[J].Endocr Rev, 1995,16:3-34.
4[4]Baughaday W H. Insulin-like growth factors 1 and 2:peptide messenger ribonucleic aicd, gene structures and serum and tissue concentration[J].Endoc Rev, 1989,10:68-91.
5[5]Juul A.Serum insulin-like growth factor 1 in 1030 healthy children, adolescents, and body mass index[J]. J Clin Endocrinol Metab, 1994,78(3):744.
6[6]Jens O L, Nina V, Tony B, et al. Determinants of serum insulin-like growth factor 1 in growth hormone deficient adults as compared to healthy subjects[J].Clin Endocrinol, 1998, 48:479.
7[7]Giudice L C, Farrell E M, Pham H, et al.Identification of insulin-like growth factor binding protein-3(LGFBP-3) and IGFBP-2 in human follicular fluid[J].Clin Endocrinol Metab, 1990,71:1330.
8[8]Miao Z R, Lin T K, Bongso T A, et al.Effect of insulin-like growth factors(IGFs) and IGF-binding proteins on in vitro sperm motility[J].Clin Endocrinol, 1998,351:1393.
9[9]Wolk A, Mantzoroas C S, Ansderesson S O, et al.Insulin-like growth factor-1 and prostate cancer risk[J]. J Natl Cancer Inst, 1998,90(2):911-5.
10[10]Stattin P, Bylund A, Rinaldi S, et al.Plasma insulin-like growth factor-1, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study[J].J Natl Cancer Inst, 2000,92(23):1910-7.
